Robert W.A. Sellers's most recent trade in Edwards Lifesciences Corp was a trade of 229 Common Stock done at an average price of $86.7 . Disclosure was reported to the exchange on May 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 229 | 17,081 (0%) | 0% | 86.7 | 19,859 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 4,820 | 4,820 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 2,445 | 17,488 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 178 | 17,310 (0%) | 0% | 85.1 | 15,146 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 120 | 15,043 (0%) | 0% | 85.3 | 10,230 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 106 | 15,163 (0%) | 0% | 85.1 | 9,016 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 1,998 | 15,085 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | W.A. Robert Sellers | SVP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 87.00 per share. | 12 Feb 2024 | 12,210 | 13,087 (0%) | 0% | 87 | 1,062,270 | Common Stock |
| Edwards Lifesciences Corp | Sellers W.A. Robert | SVP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 12 Feb 2024 | 12,210 | 25,297 (0%) | 0% | 36.8 | 448,718 | Common Stock |
| Edwards Lifesciences Corp | Robert Sellers W.A. | SVP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 12,210 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 5,540 | 5,540 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 1,800 | 13,035 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 161 | 11,235 (0%) | 0% | 88.7 | 14,287 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 134 | 11,396 (0%) | 0% | 88.7 | 11,891 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.10 per share. | 03 May 2023 | 116 | 11,530 (0%) | 0% | 88.1 | 10,220 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.81 per share. | 03 May 2023 | 103 | 11,646 (0%) | 0% | 87.8 | 9,044 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 12,270 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 87.20 per share. | 28 Apr 2023 | 12,270 | 11,749 (0%) | 0% | 87.2 | 1,069,944 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 28 Apr 2023 | 12,270 | 24,019 (0%) | 0% | 35.2 | 431,864 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.93 per share. | 17 May 2022 | 211 | 11,436 (0%) | 0% | 95.9 | 20,241 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.52 per share. | 07 May 2022 | 155 | 11,647 (0%) | 0% | 100.5 | 15,581 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.52 per share. | 07 May 2022 | 134 | 11,802 (0%) | 0% | 100.5 | 13,470 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 3,480 | 3,480 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 1,180 | 12,052 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.93 per share. | 03 May 2022 | 116 | 11,936 (0%) | 0% | 105.9 | 12,288 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | VP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.49 per share. | 17 May 2021 | 204 | 10,555 (0%) | 0% | 89.5 | 18,256 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | VP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.40 per share. | 11 May 2021 | 274 | 10,759 (0%) | 0% | 90.4 | 24,770 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | VP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.75 per share. | 07 May 2021 | 133 | 11,033 (0%) | 0% | 91.8 | 12,203 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | VP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 4,250 | 4,250 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | VP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 1,340 | 11,166 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | VP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2020 | 21,540 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Robert W.A. Sellers | VP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 82.60 per share. | 27 Aug 2020 | 21,540 | 42,040 (0%) | 0% | 82.6 | 1,779,161 | Common Stock |
| Edwards Lifesciences Corp | Robert W.A. Sellers | VP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 27 Aug 2020 | 21,540 | 63,580 (0%) | 0% | 21.8 | 468,710 | Common Stock |